The China Neonatal Genomes Project (CNGP)

Fudan University

Status: Enrolling

Conditions: Genetic Predisposition to Disease; Newborn; Defect, Congenital; Hereditary Disease

Treatments: Genetic: Genomic sequencing

Study type: Observational

Funder types: Other

Identifiers

NCT03931707

CHFudanU_NNICU11

Details and patient eligibility

About

The project will carry out the genetic testing of 100000 neonates in the next 5 years. The aim of the project is to construct the Chinese neonatal genome database, establish the genetic testing standard of neonatal genetic diseases, and promote the industrialization of neonatal genetic disease gene testing, improve the training system for genetic counseling.

Full description

There are about 900,000 new cases of birth defects in China every year. There are a large number of hereditary diseases, such as primary immune deficiency diseases, genetic metabolic diseases and multiple malformation syndrome, etc. It is important to identify and diagnose these diseases early in life, which can optimize the treatment strategy, improve the quality of life, and achieve the purpose of accurate treatment. To improve the level of diagnosis and prevention of genetic diseases in children is conducive to the birth and education of newborn in our country. The China Neonatal Genome Project is an important part of the China Human single Target Genome Project. The investigators plan to complete genetic testing of 100,000 newborns within 5 years, establish genetic testing standards for genetic diseases of newborns, and promote precise intervention for birth defects. The Genetic Counseling Branch of China Genetics Society, the Pediatrics Hospital affiliated to Fudan University and hundreds of hospitals in China jointly launched the Chinese newborn Genome Project in Shanghai, China. The project will carry out the genetic testing of 100000 neonates in the next 5 years. The study physician and genetic counselor will provide the consultation to families utilizing all available medical information. In the sequencing analysis of the study, this will include the medical history, physical exam, family history, standard newborn screening report. The aim of the project is to construct the Chinese neonatal genome database, establish the genetic testing standard of neonatal genetic diseases, and promote the industrialization of neonatal genetic disease gene testing, improve the training system for genetic counseling.

Enrollment: 100,000 estimated patients

Sex: All

Ages: Under 28 days old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 1. Both parents are of Chinese origin;
• 2. Postnatal age less than 28 days;
• 3. Can be retained to at least 1ml venous blood sample;
• 4. Biological parent or guardian's informed consent.

Exclusion criteria

• 1. the nationality of one of the parents is not the Han nationality or other national minorities;
• 2. reluctance of parents to use genetic sequencing data for subsequent research;
• 3. parents under 18 years of age or incapacitated for decision-making;
• 4. subjects older than 28 days.
• 5. multiple pregnancies;
• 6. lack of access to biological samples from which DNA can be extracted;
• 7. failure to sign informed consent

Trial design

100,000 participants in 1 patient group

Sick Neonatal Cohort, Sequencing

Description:

Infants and their parents enrolled through Neonatal Intensive Care Unit of member hospitals who are un-randomized to receive genomic sequencing. Results disclosure sessions will include a discussion of: family history report, results from standard newborn screening, any potentially medically relevant findings from the baby's medical history/physical exam, and the results of the genomic sequencing report.

Treatment:

Genetic: Genomic sequencing